Market Commentary | November 16, 2022


Positioning for a return to normal

Last Thursday, October’s CPI stormed in at 7.7% which would normally be cause for panic, but because the figure was lower than September’s, stocks soared and interest rates fell. On Tuesday PPI came in lower than estimates, furthering the perception that inflation may be on the wane. Anticipating that the Fed may soon be done with their rate hiking campaign, funds have poured into the bond markets bringing the yield on the 10-year Treasury to 3.679% at today’s close, down from 4.22% on November 7th.

We are not yet calling an end to inflation or ruling out a recession, but it seems that some institutional investors are.  The Financial Times last week reported that many big European and US hedge funds believe markets are severely oversold and they have begun buying discounted corporate debt. The high coupons and price appreciation as markets recover combine to produce compelling, risk-adjusted returns. We see similar opportunities in today’s REIT market.

Despite a majority of REITs reporting and forecasting strong earnings growth, and this year’s more than 90 dividend increases, overriding investor anxiety has pushed share prices of many good companies down by as much as 50 percent. Beyond common equities, the prices of many preferred stocks have suffered a lack of liquidity that makes them available for prices that offer going in yields of 6 to 9% and 20 to 40% upside to par. The high dividend yield and capital appreciation as markets normalize can combine to produce 13 to 16% annual returns over the next few years.

We may have been here before

Every economic cycle is different, but what we are seeing today bears strong resemblance to the environments post-2008 financial crisis or the late summer of 2020 after the COVID outbreak. During those markets, we examined the entire capital stack of our portfolio companies and repositioned to optimize returns. The results were very strong, and we are attempting to seize the opportunity again. You will likely see names you recognize, but they might be a new more advantageously priced issue within the company’s capital structure.

Our aim, as always, is to contain risk while optimizing returns.

Notes and Disclosure

Articles are provided for informational purposes only. They are not recommendations to buy or sell any security and are strictly the opinion of the writer. The information contained in these articles is impersonal and not tailored to the investment needs of any particular person. It does not constitute a recommendation that any particular security or strategy is suitable for a specific person.

Investing in publicly held securities is speculative and involves risk, including the possible loss of principal. The reader must determine whether any investment is suitable and accepts responsibility for their investment decisions.

Commentary may contain forward-looking statements that are by definition uncertain. Actual results may differ materially from our forecasts or estimations, and 2MCAC and its affiliates cannot be held liable for the use of and reliance upon the opinions, estimates, forecasts, and findings in this article.

Past performance does not guarantee future results. Investing in publicly held securities is speculative and involves risk, including the possible loss of principal. Historical returns should not be used as the primary basis for investment decisions. Although the statements of fact and data in this report have been obtained from sources believed to be reliable, 2MCAC does not guarantee their accuracy and assumes no liability or responsibility for any omissions/errors.

We routinely own and trade the same securities purchased or sold for advisory clients of 2MCAC. This circumstance is communicated to clients on an ongoing basis. As fiduciaries, we prioritize our clients’ interests above those of our corporate and personal accounts to avoid conflict and adverse selection in trading these commonly held interests.

Hypertext links to other sites are provided strictly as a courtesy. When you link to any of the sites provided on our website, you are leaving this website. We make no representation as to the completeness or accuracy of information provided on these websites. Nor is the company liable for any direct or indirect technical or system issues or any consequences arising out of your access to or your use of third-party technologies, websites, information, and programs made available through this website. When you access one of these websites, you are leaving our website and assume total responsibility and risk for your use of the websites to which you are linking.

Share This